Cyclacel Pharmaceuticals
CYCC
CYCC
27 hedge funds and large institutions have $1.63M invested in Cyclacel Pharmaceuticals in 2022 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 7 increasing their positions, 7 reducing their positions, and 4 closing their positions.
Holders
27
Holders Change
+1
Holders Change %
+3.85%
% of All Funds
0.44%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
7
Reduced
7
Closed
4
Calls
$12K
Puts
–
Net Calls
+$12K
Net Calls Change
–
Top Buyers
1 |
SSA
1
Schonfeld Strategic Advisors
New York
|
$514K |
2 |
BCM
2
Bridgeway Capital Management
Houston,
Texas
|
$42.7K |
3 |
HF
3
HRT Financial
New York
|
$27K |
4 |
E
4
Ergoteles
New York
|
$17.3K |
5 |
VF
5
Virtu Financial
New York
|
$16K |